SU1496799A1 - Method of treatment of uterus myoma - Google Patents
Method of treatment of uterus myoma Download PDFInfo
- Publication number
- SU1496799A1 SU1496799A1 SU874306918A SU4306918A SU1496799A1 SU 1496799 A1 SU1496799 A1 SU 1496799A1 SU 874306918 A SU874306918 A SU 874306918A SU 4306918 A SU4306918 A SU 4306918A SU 1496799 A1 SU1496799 A1 SU 1496799A1
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- day
- treatment
- administered
- eleutherococcus
- dihydroergotamine
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Изобретение относитс к гинекологии. Цель изобретени - предупреждение побочного действи . Дл этого ввод т дифенин по 2 таблетки в день, настойку элеутерококка по 20 капель 2 раза в день, с 10-го дн менструального цикла ввод т дигидроэрготамин по 15 капель 2 раза в день в течение 10 дней не менее 2 курсов. Это позвол ет нормализовать психоэмоциональное состо ние, ликвидировать боли, снизить кровопотерю у 94,4%,уменьшить размеры матки у 95,8% больных.This invention relates to gynecology. The purpose of the invention is to prevent side effects. To do this, difenin is administered 2 tablets per day, Eleutherococcus tincture, 20 drops 2 times a day, from the 10th day of the menstrual cycle, dihydroergotamine 15 drops 2 times a day for 10 days at least 2 courses are administered. This allows to normalize the psycho-emotional state, eliminate pain, reduce blood loss in 94.4%, and reduce the size of the uterus in 95.8% of patients.
Description
Изобретение относитс к медицине, а именно к гинекологии.The invention relates to medicine, namely to gynecology.
Целью изобретени вл етс предупреждение побочного действи от введени лекарственных средств.The aim of the invention is to prevent side effects from the administration of drugs.
Пример. Больна Н., 43 лет, обратилась с жалобами на боли в нижних отделах живота, больна в течение 6 лет. Диагноз при поступлении; миома матки. Цри обследовании размер образовани соответствует 8-недельному сроку беременности, количество лимфоцитов 1782, Т-лимфоцитов 56%, содержание дофамина в суточной моче 1453 нмоль/сут; норадреналина 163,2 нмоль/сут, адреналина 74,2 нмоль/сут, серотонина 1,82 мкмоль/л, адаптационна реакци тренировки. Назначено: дифенин по 2 таблетки в день, настойка элеутерококка по 20 капель 2 раза в день, с 10-го дн очередного менструального цикла дигидроэрготамин по 15 капель 2 раза в день до 19 дн цикла включительно; лечение дифе- нином и настойкой элеутерококка продолжалось непрерывно в течение 2 мес., дигидроэрготамин повторно добавлен с 10-го дн второго менструального цикла на 10 дней.Example. Ill N., 43 years old, complained of pain in the lower abdomen, ill for 6 years. Diagnosis at admission; uterine fibroids. According to the survey, the size of the formation corresponds to an 8-week gestation, the number of lymphocytes is 1782, T-lymphocytes is 56%, the content of dopamine in daily urine is 1,453 nmol / day; norepinephrine 163.2 nmol / day, adrenaline 74.2 nmol / day, serotonin 1.82 µmol / l, training adaptation reaction. Appointed: difenin 2 tablets per day, tincture of Eleutherococcus 20 drops 2 times a day, from the 10th day of the next menstrual cycle dihydroergotamine 15 drops 2 times a day until the 19th day of the cycle, inclusive; treatment with difenin and tincture of eleutherococcus continued uninterruptedly for 2 months, dihydroergotamine was re-added from the 10th day of the second menstrual cycle for 10 days.
После проведени курса лечени при обследовании размеры матки соответствуют 6-7-недельному сроку беременности, боли отсутствуют, количество лимфоцитов 1830, Т-лимфоцитов 62%, уровень экскретируемого дофамина 1605,1 нмоль/сут; норадреналина 136,1 нмоль/сут, адреналина 48,3 нмоль/сут, серотонина 1,1 мкмоль/л.After the course of treatment, during examination, the size of the uterus corresponds to 6-7 weeks of gestation, there is no pain, the number of lymphocytes is 1830, T-lymphocytes are 62%, the level of excreted dopamine is 1,605.1 nmol / day; norepinephrine 136.1 nmol / day, adrenaline 48.3 nmol / day, serotonin 1.1 μmol / l.
Способ лечени апробирован на 72 больных с различным клиническим течением миомы матки. После лечени у всех больных установлена нормализаци психоэмоционального состо ни и ликвидаци болей; снижение менструальной кровопотери у 94,4%, стабилизаци и уменьшение размеров матки у 95,8% больных.The treatment method was tested on 72 patients with different clinical course of uterine fibroids. After treatment, all patients established normalization of the psycho-emotional state and the elimination of pain; reduction of menstrual blood loss in 94.4%, stabilization and reduction in the size of the uterus in 95.8% of patients.
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SU874306918A SU1496799A1 (en) | 1987-09-17 | 1987-09-17 | Method of treatment of uterus myoma |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SU874306918A SU1496799A1 (en) | 1987-09-17 | 1987-09-17 | Method of treatment of uterus myoma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SU1496799A1 true SU1496799A1 (en) | 1989-07-30 |
Family
ID=21328066
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SU874306918A SU1496799A1 (en) | 1987-09-17 | 1987-09-17 | Method of treatment of uterus myoma |
Country Status (1)
| Country | Link |
|---|---|
| SU (1) | SU1496799A1 (en) |
-
1987
- 1987-09-17 SU SU874306918A patent/SU1496799A1/en active
Non-Patent Citations (1)
| Title |
|---|
| Вихл ева Е. М. Обоснование консервативного лечебного воздействи при миоме матки.- В кн.: Фибромиома матки. Тезисы Т симпозиума, Кишинев, 1976, с. 53-57. * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bluntschli, HJ*** & Goetz | The effect of a new sympathicolytic drug (dihydroergocornine) on the blood-pressure with special reference to hypertension | |
| SU1496632A3 (en) | Method of producing substituted benzamides | |
| Lombardo et al. | Subarachnoid hemorrhage due to endometriosis of the spinal canal | |
| SU1496799A1 (en) | Method of treatment of uterus myoma | |
| HAFKENSCHIEL et al. | 1-Hydrazinophthalazine (Apresoline in the) reatment of Hypertension: A Two Year Study | |
| Barrow et al. | The use of purified veratrum viride alkaloids in the treatment of essential hypertension | |
| Starling | THE CHEMICAL CONTROL OF THE BODY. | |
| CN115475162B (en) | Application of 4-isobutyl-2-pyrrolidone in preparing analgesic drug and analgesic drug | |
| Lamazza et al. | Effects of pinaverium bromide in the premedication of endoscopic retrograde cholangio-pancreatography and on motor activity of the sphincter of Oddi | |
| Dieckmann et al. | The effects of intravenous injections of ergonovine and solution of posterior pituitary extract on the postpartum patient | |
| Reynolds et al. | A double-blind cross-over trial of prenazone (DA 2370) and phenylbutazone in rheumatoid arthritis | |
| Rosenberg et al. | Myopathy from surreptitious ipecac ingestion. | |
| SU1487907A1 (en) | Method of treating ovular paints | |
| von Mandach et al. | Pharmacokinetic studies on fenoterol in maternal and cord blood | |
| SCOTT et al. | The treatment of angina pectoris with pure crystalline khellin | |
| Ansari et al. | Thyrotoxicosis in a mongol. | |
| SU1713597A1 (en) | Method for treating the cases of hypotension in pregnant women | |
| JACKSON | The autonomic system as an integrator with special reference to the urogenital organs | |
| Panda | Concise Pocket Medical Dictionary | |
| RU2268057C1 (en) | Method for preparing high-risk group pregnant women for delivery because of the development of abnormalities of birth activity | |
| RU1804851C (en) | Method for treatment chronic inflammatory processes by inner female genital organs | |
| RU2083211C1 (en) | Method to treat acute uterine inflammatory diseases | |
| Bol | Successful artificial insemination with spermatozoa recovered from the urine in a case of retrograde ejaculation | |
| RU2152223C1 (en) | Method for treating chronic polymyositis | |
| Waller et al. | Myasthenia Gravis and Hyperthyroidism—A Report of Two Cases |